| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
We have designed a novel peptide, DP1, which is able to mediate significant induction of apoptosis in solid tumors by local injection. This peptide, comprised of a protein transduction domain (PTD), PTD-5, fused to an antimicrobial peptide, (KLAKLAK)2, was able to trigger rapid apoptosis in a variety of cell lines in vitro, including MCA205 murine fibrosarcomas and human head and neck tumors. Furthermore, direct injection of DP1 into day 7 established MCA205 tumors in C57BL/6 mice resulted in the induction of tumor apoptosis and subsequent reduction in tumor volume. These results suggest that DP1 may be used clinically to treat accessible solid tumors or as an adjuvant therapy in conjunction with radiotherapy, standard chemotherapy, immunotherapy, or surgical debulking.
This article has been cited by other articles:
![]() |
E. Kondo, T. Tanaka, T. Miyake, T. Ichikawa, M. Hirai, M. Adachi, K. Yoshikawa, K. Ichimura, N. Ohara, A. Moriwaki, et al. Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines Mol. Cancer Ther., June 1, 2008; 7(6): 1461 - 1471. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Dave, J. S. Tilstra, K. Matsuoka, F. Li, T. Karrasch, J. K. Uno, A. R. Sepulveda, C. Jobin, A. S. Baldwin, P. D. Robbins, et al. Amelioration of Chronic Murine Colitis by Peptide-Mediated Transduction of the I{kappa}B Kinase Inhibitor NEMO Binding Domain Peptide J. Immunol., December 1, 2007; 179(11): 7852 - 7859. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Ko, K.-H. Choi, Z. Pan, P. Lin, N. Weisleder, C.-W. Kim, and J. Ma The tail-anchoring domain of Bfl1 and HCCS1 targets mitochondrial membrane permeability to induce apoptosis J. Cell Sci., August 15, 2007; 120(16): 2912 - 2923. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rege, S. J. Patel, Z. Megeed, and M. L. Yarmush Amphipathic Peptide-Based Fusion Peptides and Immunoconjugates for the Targeted Ablation of Prostate Cancer Cells Cancer Res., July 1, 2007; 67(13): 6368 - 6375. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rotem, I. Radzishevsky, and A. Mor Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives. Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2666 - 2672. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Law, L. Quinti, Y. Choi, R. Weissleder, and C.-H. Tung A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity. Mol. Cancer Ther., August 1, 2006; 5(8): 1944 - 1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Papo, A. Braunstein, Z. Eshhar, and Y. Shai Suppression of Human Prostate Tumor Growth in Mice by a Cytolytic D-, L-Amino Acid Peptide: Membrane Lysis, Increased Necrosis, and Inhibition of Prostate-Specific Antigen Secretion Cancer Res., August 15, 2004; 64(16): 5779 - 5786. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takada, S. Singh, and B. B. Aggarwal Identification of a p65 Peptide That Selectively Inhibits NF-{kappa} B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-{kappa}B-mediated Gene Expression and Up-regulation of Apoptosis J. Biol. Chem., April 9, 2004; 279(15): 15096 - 15104. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagel-Wolfrum, C. Buerger, I. Wittig, K. Butz, F. Hoppe-Seyler, and B. Groner The Interaction of Specific Peptide Aptamers With the DNA Binding Domain and the Dimerization Domain of the Transcription Factor Stat3 Inhibits Transactivation and Induces Apoptosis in Tumor Cells Mol. Cancer Res., March 1, 2004; 2(3): 170 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Zurita, P. Troncoso, M. Cardo-Vila, C. J. Logothetis, R. Pasqualini, and W. Arap Combinatorial Screenings in Patients: The Interleukin-11 Receptor {alpha} as a Candidate Target in the Progression of Human Prostate Cancer Cancer Res., January 15, 2004; 64(2): 435 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Mai, H. Shen, S. C. Watkins, T. Cheng, and P. D. Robbins Efficiency of Protein Transduction Is Cell Type-dependent and Is Enhanced by Dextran Sulfate J. Biol. Chem., August 9, 2002; 277(33): 30208 - 30218. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |